Inhalable Biologics Market Size, Share & Trends Report

Inhalable Biologics Market (2025 - 2030) Size, Share & Trends Analysis Report By Biologics (Peptides & Proteins, Monoclonal Antibodies, RNAi-based Therapeutics), By Application (Diabetes, Cancer), By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts

Market Segmentation

Inhalable Biologics Type Outlook (Revenue, USD Million, 2018 - 2030)
- Peptides and Proteins
- Vaccines
- Monoclonal Antibodies
- RNAi-based Therapeutics
- Others
Inhalable Biologics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Respiratory diseases
  - COPD
  - Asthma
  - Cystic Forbis
  - Covid-19
  - Others
- Diabetes
- Cancer
- Others
Inhalable Biologics Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)
- Dry Powder Inhalers
- Metered Dose Inhalers
- Nebulizers
- Others
Inhalable Biologics Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Inhalable Biologics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Inhalable Biologics Market, by Type
    - Peptides and Proteins
    - Vaccines
    - Monoclonal Antibodies
    - RNAi-based Therapeutics
    - Others
  - North America Inhalable Biologics Market, by Application
    - Respiratory diseases
      - COPD
      - Asthma
      - Cystic Forbis
      - Covid-19
      - Others
    - Diabetes
    - Cancer
    - Others
  - North America Inhalable Biologics Market, by Dosage Form
    - Dry Powder Inhalers
    - Metered Dose Inhalers
    - Nebulizers
    - Others
  - North America Inhalable Biologics Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - U.S.
    - U.S. Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - U.S. Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - U.S. Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - U.S. Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Canada
    - Canada Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Canada Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Canada Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Canada Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Mexico
    - Mexico Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Mexico Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Mexico Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Mexico Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
- Europe
  - Europe Inhalable Biologics Market, by Type
    - Peptides and Proteins
    - Vaccines
    - Monoclonal Antibodies
    - RNAi-based Therapeutics
    - Others
  - Europe Inhalable Biologics Market, by Application
    - Respiratory diseases
      - COPD
      - Asthma
      - Cystic Forbis
      - Covid-19
      - Others
    - Diabetes
    - Cancer
    - Others
  - Europe Inhalable Biologics Market, by Dosage Form
    - Dry Powder Inhalers
    - Metered Dose Inhalers
    - Nebulizers
    - Others
  - Europe Inhalable Biologics Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - UK
    - UK Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - UK Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - UK Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - UK Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Germany
    - Germany Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Germany Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Germany Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Germany Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - France
    - France Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - France Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - France Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - France Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Italy
    - Italy Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Italy Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Italy Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Italy Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Spain
    - Spain Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Spain Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Spain Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Spain Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Denmark
    - Denmark Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Denmark Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Denmark Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Denmark Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Sweden
    - Sweden Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Sweden Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Sweden Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Sweden Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Norway
    - Norway Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Norway Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Norway Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Norway Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
- Asia Pacific
  - Asia Pacific Inhalable Biologics Market, by Type
    - Peptides and Proteins
    - Vaccines
    - Monoclonal Antibodies
    - RNAi-based Therapeutics
    - Others
  - Asia Pacific Inhalable Biologics Market, by Application
    - Respiratory diseases
      - COPD
      - Asthma
      - Cystic Forbis
      - Covid-19
      - Others
    - Diabetes
    - Cancer
    - Others
  - Asia Pacific Inhalable Biologics Market, by Dosage Form
    - Dry Powder Inhalers
    - Metered Dose Inhalers
    - Nebulizers
    - Others
  - Asia Pacific Inhalable Biologics Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - China
    - China Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - China Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - China Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - China Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Japan
    - Japan Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Japan Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Japan Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Japan Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - India
    - India Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - India Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - India Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - India Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Australia
    - Australia Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Australia Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Australia Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Australia Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - South Korea
    - South Korea Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - South Korea Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - South Korea Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - South Korea Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Thailand
    - Thailand Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Thailand Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Thailand Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Thailand Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
- Latin America
  - Latin America Inhalable Biologics Market, by Type
    - Peptides and Proteins
    - Vaccines
    - Monoclonal Antibodies
    - RNAi-based Therapeutics
    - Others
  - Latin America Inhalable Biologics Market, by Application
    - Respiratory diseases
      - COPD
      - Asthma
      - Cystic Forbis
      - Covid-19
      - Others
    - Diabetes
    - Cancer
    - Others
  - Latin America Inhalable Biologics Market, by Dosage Form
    - Dry Powder Inhalers
    - Metered Dose Inhalers
    - Nebulizers
    - Others
  - Latin America Inhalable Biologics Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Brazil
    - Brazil Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Brazil Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Brazil Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Brazil Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Argentina
    - Argentina Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Argentina Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Argentina Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Argentina Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
- Middle East & Africa
  - Middle East & Africa Inhalable Biologics Market, by Type
    - Peptides and Proteins
    - Vaccines
    - Monoclonal Antibodies
    - RNAi-based Therapeutics
    - Others
  - Middle East & Africa Inhalable Biologics Market, by Application
    - Respiratory diseases
      - COPD
      - Asthma
      - Cystic Forbis
      - Covid-19
      - Others
    - Diabetes
    - Cancer
    - Others
  - Middle East & Africa Inhalable Biologics Market, by Dosage Form
    - Dry Powder Inhalers
    - Metered Dose Inhalers
    - Nebulizers
    - Others
  - Middle East & Africa Inhalable Biologics Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - South Africa
    - South Africa Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - South Africa Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - South Africa Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - South Africa Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Saudi Arabia
    - Saudi Arabia Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Saudi Arabia Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Saudi Arabia Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Saudi Arabia Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - UAE
    - UAE Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - UAE Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - UAE Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - UAE Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Kuwait
    - Kuwait Inhalable Biologics Market, by Type
      - Peptides and Proteins
      - Vaccines
      - Monoclonal Antibodies
      - RNAi-based Therapeutics
      - Others
    - Kuwait Inhalable Biologics Market, by Application
      - Respiratory diseases
        
        COPD
        
        Asthma
        
        Cystic Forbis
        
        Covid-19
        
        Others
      - Diabetes
      - Cancer
      - Others
    - Kuwait Inhalable Biologics Market, by Dosage Form
      - Dry Powder Inhalers
      - Metered Dose Inhalers
      - Nebulizers
      - Others
    - Kuwait Inhalable Biologics Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments